Legal & General Group Plc Acquires Shares of 285,144 National Health Investors, Inc. $NHI

Legal & General Group Plc bought a new position in shares of National Health Investors, Inc. (NYSE:NHI) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 285,144 shares of the real estate investment trust’s stock, valued at approximately $21,745,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of NHI. International Assets Investment Management LLC bought a new position in shares of National Health Investors in the fourth quarter valued at approximately $27,000. EverSource Wealth Advisors LLC lifted its holdings in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares during the period. Garton & Associates Financial Advisors LLC bought a new stake in National Health Investors during the fourth quarter worth $33,000. Allworth Financial LP purchased a new position in National Health Investors in the second quarter worth $42,000. Finally, Advisory Services Network LLC purchased a new position in National Health Investors in the third quarter worth $65,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Performance

NYSE:NHI opened at $71.96 on Friday. The company has a market capitalization of $3.53 billion, a P/E ratio of 20.80, a P/E/G ratio of 3.83 and a beta of 0.51. The business has a fifty day simple moving average of $75.68 and a two-hundred day simple moving average of $78.76. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. National Health Investors, Inc. has a 1 year low of $67.94 and a 1 year high of $91.38.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The firm had revenue of $121.32 million for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, analysts expect that National Health Investors, Inc. will post 4.78 earnings per share for the current year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.1%. National Health Investors’s dividend payout ratio is 108.67%.

Insider Activity

In other National Health Investors news, CEO D. Eric Mendelsohn purchased 1,500 shares of the stock in a transaction dated Friday, June 5th. The shares were bought at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This represents a 2.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 2.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on NHI shares. Deutsche Bank Aktiengesellschaft decreased their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, June 25th. Truist Financial cut their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Finally, BMO Capital Markets lowered their price objective on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.86.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.